Genevac announces the launch of a new second-generation version of
its EZ-2 centrifugal evaporator, which is able to take tubes,
flasks and vials directly from the synthesis process, providing
flexibility for those switching their...
UK company ComplianceControl is launching new software to
streamline the compliance control process, saving precious time and
money for pharmaceutical manufacturing companies of all sizes.
Global medical technology company Gambro has had imports of its
kidney dialysis monitors into the US blocked by the US Food and
Drug Administration (FDA) after a failed plant inspection in
September.
Supernus Pharmaceuticals has acquired the drug formulation business
of Shire Laboratories (SLI) in a move that strengthens the
pharmaceutical technologies and services. The company will make use
of the patents to improve its own portfolio...
Biotage has acquired exclusive rights to an evaporation technology,
which substantially reduces sample-drying time for pharmaceutical
chemists, meeting the need to relieve a major bottleneck in
chemistry and drug development.
As worldwide fears of a bird flu pandemic escalates, US border control are fighting an influx of fake Tamiflu products being imported into the country. Such products have been surfacing across the country as the global Tamiflu shortage has led to a scramble...
Canadian biotech company Generex has begun a study of its flagship
oral insulin spray in patients with Type-1 diabetes. The product,
already available for type 2 diabetes in Ecuador, was the first
non-injectable form of insulin to...
Innovata has backed out of discussions for the possible "all-share"
takeover of beleaguered drug development company SkyePharma, citing
its inability to be competitive with cash-based offers from other
companies.
Bayer has acquired Icon Genetics in a culmination of an existing
agreement between the two companies. The deal also solidifies
Bayer's direction as it soughts to strengthen its efforts to
produce specific plant-made pharmaceuticals.
Maxxon are to receive delivery of the first 5,000 batch of its
functional 3 cc Vacuum Operated Retractable Safety Syringe
("ReVac"), which is set to spark a price war amongst fellow
manufacturers in the Safety-engineered...
VirtualScopics reported a breakthrough year in 2005, doubling its
customer base to 26 and reaping in more than $5 m (€4.1 m) worth of
business, an increase from the previous year of over 100 per cent.
Hill Top Research, one of the leading clinical research services
companies in the US, has positioned itself for growth after last
week's acquisition by Utah's DW Healthcare Partners, a private
equity firm focused on the...
Researchers are looking into the possibility of using a protein
that undesirably shields a skin poxvirus from the immune system as
the key ingredient in a new topical treatment for inflammatory
diseases.
ADME/toxicity service providers, Cyprotex, launch a new service to
help drug discovery groups assess new oral drug candidates. The
service will equip researchers with new pharmacokinetic insights as
early as possible, aiming to improve...
Sigma Aldrich has launched a new integrated lysis and affinity
purification (iLAP) column, which greatly simplifies the process of
cell lysis and histidine-tagged protein purification into one step,
allowing fast, efficient and non-denaturing...
AIDS researchers have uncovered new evidence, which points to the
'fitness' of the HIV virus as a primary factor in explaining
different resistant patterns to the drugs that treat the disease.
A new report reveals that a lack of validation amongst drug
discovery processes has emerged as a major restraint to the uptake
and penetration levels of computational biology tools in the drug
discovery industry.
UK's In2Focus Healthcare Technologies has formed a strategic
alliance with Canadian based IsaiX Technologies, to co-promote each
other's IT technology services for the pharma industry in Europe
and North America.
CFC International is to be acquired by Quad-C Management in a move
that aims to capitalise on the worldwide demand for CFC
International products that include hot stamp foils and heat
transferable labels for intravenous solution bags,...
Shimadzu make available the World's first network-enabled
controller that allows web browser access of High Performance
Liquid Chromatograph (HPLC) allowing laboratory researchers to
control and monitor their Prominence and VP...
Chromos has announced an expansion to an existing Pfizer
collaboration, which builds on research focusing on genetic
engineering of production cell lines with multiple genes to improve
bioreactor performance and reduce monoclonal...
EntreMed have entered into a new agreement with Elan, which allows
the clinical-stage pharmaceutical company to utilise Elan's
NanoCrystal Technology to develop the oncology product candidate,
Panzem NCD.
MedImmune will soon ramp up production of its intranasal flu
vaccine after the US Food and Drug Administration (FDA) approved
its new and larger flu vaccine manufacturing facility in Speke,
England.
Centocor has enlisted Cardinal Health to use its rapid cell line
development technology to engineer cell lines expressing Centocor's
monoclonal antibodies, and speed up the development of new
biopharmaceuticals.
Indian IT company Tata Consultancy Services (TCS) has scored a
contract from Danish pharma company Novo Nordisk for the data
management of its clinical trials run in India.
Scynexis Europe is to operate under the name Selcia after Scynexis
sold its subsidiary in the United Kingdom to its UK management in a
move that allows Selcia to provide custom radiolabeling, chemistry
and analytics services to a...
New drugs that are based on a compound found in the body may give
renewed hope to stroke victims and sufferers of degenerative brain
diseases such as Alzheimer's as researchers are hopeful of a new
therapeutic approach.
Pfizer has announced the expansion of an existing collaboration
with Sangamo Biosciences, which will use zinc finger DNA-binding
protein (ZFP) technology to develop additional cell lines for
enhanced protein production.
NanoDrop Technologies has introduced new software for the NanoDrop
ND-1000 UV/Vis Spectrophotometer, which aims to make it an even
more powerful and convenient tool for measuring 1 ul samples.
Velocity11 has announced a new configuration of its BioCel
sample-processing platform that will allow all cell-based Elisa
procedures to become fully automated, reducing the risk of human
error, contamination and time spent on tedious...
UK's Pharmagene has joined forces with US company Asterand to form
a human tissue supply and research services company that will
dominate the pharma industry. The merger, which was finalised last
week, will also solidify Pharmagene's...
Nastech have found four new classes of lipids that can be used to
enhance transmucosal drug delivery and open up new opportunities
for non-injectable forms of drugs that would otherwise require
injections.
After months of speculation, chemical giants BASF have put in a
$4.9 billion (€4.1 billion) offer for the Engelhard Corporation,
which if successful, would become BASF's largest acquisition to
date, surpassing Dow Chemical as...
Buccal drug delivery pioneer, Generex, is expanding its diabetes
treatment pipeline to include a new metformin chewing gum that aims
to avoid the significant adverse gastrointestinal side-effects
often accompanying the use of metformin...
Indian drug maker Shasun Chemicals & Drugs has agreed to buy
the customs synthesis business of French company Rhodia Pharma
Solutions, in a move to strengthen its global presence in active
pharmaceutical ingredient (API), custom...
Baxa has announced it is to move to direct sales and marketing
operations in Europe, bringing to an end its existing business
strategy, which sold its products through exclusive distributors,
with support provided by Baxa from their...
The firing of Dr Peter Rost by Pfizer highlights the position that
employees can be faced with if they take a stand on what they
believe to be illegal activity in the companies they work for.
A restructure of DSM's pharma businesses will see the closure of
its Pharma Chemicals site in Michigan, US, in the first half of
2007 and the mothballing of the DSM Biologics facilities in
Montreal, Canada at the beginning of...
Australian company pSivida has completed its acquisition of US drug
delivery firm, Control Delivery Systems (CDS), as part of its
strategy to expand its presence in the US biotech industry.
A new study is underway in the US to define the technical knowledge
and expertise required by professionals involved in drug product
development and manufacturing. The results will form a basis for a
new global credentialing program...
According to a new report, the costs of clinical development are
rising more rapidly in relation to the other parts of the R&D
process, placing greater emphasis on the recruitment of test
subjects, as clinical trial service...
Research undertaken by Nastech has uncovered that endothelial tight
junctions play a role in atherosclerosis, which may provide new
therapeutic targets for cardiovascular disease.
Lonza has scored a manufacturing contract to help Bristol
Myers-Squibb (BMS) meet anticipated demand of its newly approved
drug that will offer a new treatment option for rheumatoid
arthritis, a disease that afflicts more than two...
With two acquisitions in two months, US biotechnology major Genzyme
has strengthened and diversified its ability to develop gene
therapy products that use either adenovirus or adeno-associated
virus vectors.
Leading contract research organisation, Covance, has upgraded its
software to streamline the laboratory testing aspect of its
clinical trials and allow sponsoring drug companies greater
involvement in the overall process.
Ventiv's Clinical Services division has joined with India's largest
domestic contract research organization (CRO), SIRO Clinpharm, to
provide India-based clinical data management services, offering
pharma and biotech companies...
The expiration of the Polymerase Chain Reaction (PCR) patent is set
to offer growth opportunities for nucleic acid purification and
amplification technologies, particularly for small companies, who
can offer tests without developing...
Dutch biotechnology company Crucell continues to push its PER.C6
cell line forward into the worldwide market, with a new agreement
now enabling the revolutionary vaccine technology to be used to
manufacture vaccines in Canada.
Near-infrared (NIR) chemical imaging is emerging as the analytical
tool of choice for drug formulation development, analysis and
process monitoring of the increasing number of advanced drug
delivery systems.
A new range of high-speed automatic capsule filling machines has
been launched by UK's Hanningfield Process Systems that are
suitable for most types of hard shell capsule, and offer
pharmaceutical manufacturers rapid capsule...
